(Q40483034)

20 September 2017

1 reference

title

Malaria: toxins, cytokines and disease. (English)

1 reference

20 September 2017

0 references

4

Playfair JH

1 reference

20 September 2017

Jakobsen PH

1

1 reference

PubMed ID

7675508

20 September 2017

Bate CA

series ordinal

2

1 reference

PubMed ID

7675508

20 September 2017

Taverne J

series ordinal

3

1 reference

20 September 2017

1 May 1995

1 reference

20 September 2017

1 reference

20 September 2017

17

1 reference

20 September 2017

223-231

1 reference

20 September 2017

5

1 reference

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

The binding site on ICAM-1 for Plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Proposed link between cytokines, nitric oxide and human cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Interactions between cytokines and α2-macroglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Pentoxifylline prevents murine cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Why is malaria fever periodic? A hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Effect of Plasmodium falciparum malaria infection on the plasma concentration of alpha 1-acid glycoprotein and the binding of quinine in Malawian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Tumour necrosis factor, interleukin-6, and malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

The malaria vaccine: anti-parasite or anti-disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Immune response to soluble exoantigens of Plasmodium falciparum may contribute to both pathogenesis and protection in clinical malaria: evidence from a longitudinal, prospective study of semi-immune African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Acute Phase Protein, Serum Amyloid A, Inhibits IL-1- and TNF-Induced Fever and Hypothalamic PGE2 in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Selective damage of hippocampal neurons in murine cerebral malaria prevented by pentoxifylline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Unravelling the cytokine network in Malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Malarial toxic antigens synergistically enhance insulin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

Isolation of dengue 2 and dengue 4 viruses from patients in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

DNA-binding antibodies and parasitic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1995.TB01019.X

10.1111/J.1365-3024.1995.TB01019.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7675508